Table 1. Descriptive statistics of patients and tumor characteristics are shown for those (A) employing whole genome microarray (mRNA) and NGS (small RNAs including miRNAs) and (b) using qRT-PCR for selected 95 different miRNAs.
metastasis subtype | descriptive statistic | age at diagnosis (years) | tumor size (mm) | initial clinical stage |
A) whole genome microarray and NGS analysis | ||||
detectable | mean | 45,2 | 37,8 | cSIIb-c |
stdev | 10,8 | 14,9 | ||
min | 31,6 | 12,0 | ||
max | 60,7 | 50,0 | ||
n | 5 | |||
occult | mean | 32,1 | 38,6 | cSI |
stdev | 5,4 | 16,2 | ||
min | 23,4 | 18,0 | ||
max | 36,6 | 55,0 | ||
n | 5 | |||
p-value | 0,04 | 0,9 | ||
B) qRT-PCR | ||||
detectable | mean | 37,4 | 49,4 | cSIIb-c |
stdev | 7,2 | 35,1 | ||
min | 21,1 | 10,0 | ||
max | 51,6 | 180,0 | ||
n | 36 | |||
occult | mean | 45,4 | 45,8 | cSI |
stdev | 4,5 | 21,0 | ||
min | 38,0 | 24,0 | ||
max | 51,0 | 80,0 | ||
n | 5 | |||
p-value | 0,02 | 0,8 |
P-values were calculated using either the t-test or a non-parametric Mann-Whitney rank sum test where applicable.